Bicycle Therapeutics Plc (BCYC)
3.36
-0.09
(-2.61%)
USD |
NASDAQ |
Nov 13, 16:00
3.36
0.00 (0.00%)
After-Hours: 19:59
Bicycle Therapeutics Market Cap : 169.87M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 174.42M |
| November 11, 2026 | 186.55M |
| November 10, 2026 | 186.55M |
| November 09, 2026 | 190.59M |
| November 06, 2026 | 182.50M |
| November 05, 2026 | 175.93M |
| November 04, 2026 | 188.06M |
| November 03, 2026 | 185.54M |
| November 02, 2026 | 183.01M |
| October 30, 2026 | 185.03M |
| October 29, 2026 | 193.12M |
| October 28, 2026 | 196.15M |
| October 27, 2026 | 191.10M |
| October 26, 2026 | 183.87M |
| October 23, 2026 | 178.84M |
| October 22, 2026 | 183.37M |
| October 21, 2026 | 179.84M |
| October 20, 2026 | 181.35M |
| October 19, 2026 | 178.08M |
| October 16, 2026 | 174.30M |
| October 15, 2026 | 181.35M |
| October 14, 2026 | 176.82M |
| October 13, 2026 | 182.87M |
| October 12, 2026 | 191.43M |
| October 09, 2026 | 195.96M |
| Date | Value |
|---|---|
| October 08, 2026 | 191.93M |
| October 07, 2026 | 187.90M |
| October 06, 2026 | 190.93M |
| October 05, 2026 | 202.01M |
| October 02, 2026 | 170.27M |
| October 01, 2026 | 179.34M |
| September 30, 2026 | 185.38M |
| September 29, 2026 | 183.87M |
| September 28, 2026 | 186.90M |
| September 25, 2026 | 185.64M |
| September 24, 2026 | 187.90M |
| September 23, 2026 | 181.35M |
| September 22, 2026 | 187.90M |
| September 21, 2026 | 182.87M |
| September 18, 2026 | 183.87M |
| September 17, 2026 | 185.38M |
| September 16, 2026 | 183.37M |
| September 15, 2026 | 184.88M |
| September 14, 2026 | 195.96M |
| September 11, 2026 | 194.45M |
| September 10, 2026 | 192.94M |
| September 09, 2026 | 201.76M |
| September 08, 2026 | 210.57M |
| September 04, 2026 | 216.62M |
| September 03, 2026 | 213.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 310.29M |
| DBV Technologies SA | 698.16M |
| Cellectis SA | 119.83M |
| Akari Therapeutics Plc | 12.13M |
| Biodexa Pharmaceuticals Plc | 2.220B |
Market Cap Related Metrics
| PS Ratio | 2.807 |
| Price to Book Value | 0.4654 |
| Price | 3.36 |
| Earnings Yield | -60.52% |